AVTECH's Q2 landed on the preannounced figures — net sales 1% above Redeye's estimate, EBITDA 13% below. AVTECH disclosed its most detailed customer pipeline to date: completed proof-of-concept trials with two medium-sized carriers, trials agreed with two further carriers of which one is very large, seven to eight other medium-sized airlines in dialogue, and a European aircraft manufacturer using Aventus for internal testing. The LATAM update repeated the previous message of a one-to-two-month pause. Redeye reads today's share move as a response to the pipeline disclosure and continues to see a LATAM restart as the near-term trigger. Estimates are unchanged and the Base Case stays at SEK9.
LÄS MER
